TipRanks
Shin Nippon Biomedical Laboratories, Ltd. (JP:2395)
:2395
Japanese Market
2395
Shin Nippon Biomedical Laboratories, Ltd.
RESEARCH TOOLSreports
Want to see JP:2395 full AI Analyst Report?

Shin Nippon Biomedical Laboratories, Ltd. (2395) Ratios

2 Followers

Shin Nippon Biomedical Laboratories, Ltd. Ratios

JP:2395's free cash flow for Q1 2026 was ¥0.51. For the 2026 fiscal year, JP:2395's free cash flow was decreased by ¥ and operating cash flow was ¥0.07. See a summary of the company’s cash flow.
Ratios
TTM
Mar 26Mar 25Mar 24Mar 23
Liquidity Ratios
Current Ratio
 1.02 1.09 1.13 1.31 1.14
Quick Ratio
 0.58 0.71 0.69 0.78 0.79
Cash Ratio
 0.36 0.47 0.41 0.44 0.50
Solvency Ratio
 0.15 0.13 0.14 0.18 0.25
Operating Cash Flow Ratio
 0.00 0.21 0.24 0.09 0.19
Short-Term Operating Cash Flow Coverage
 0.00 0.42 0.59 0.27 0.45
Net Current Asset Value
¥ -17.80B¥ -18.58B¥ -19.39B¥ -11.30B¥ -6.98B
Leverage Ratios
Debt-to-Assets Ratio
 0.38 0.39 0.37 0.34 0.33
Debt-to-Equity Ratio
 0.90 0.96 0.86 0.77 0.72
Debt-to-Capital Ratio
 0.47 0.49 0.46 0.43 0.42
Long-Term Debt-to-Capital Ratio
 0.29 0.33 0.36 0.35 0.27
Financial Leverage Ratio
 2.40 2.44 2.31 2.24 2.18
Debt Service Coverage Ratio
 0.29 0.22 0.63 0.94 0.86
Interest Coverage Ratio
 9.07 9.05 14.72 29.99 41.94
Debt to Market Cap
 0.67 0.69 0.57 0.42 0.16
Interest Debt Per Share
 910.99 998.09 836.12 632.36 453.65
Net Debt to EBITDA
 2.99 3.73 2.56 1.77 0.87
Profitability Margins
Gross Profit Margin
49.55%48.66%51.12%54.00%52.00%
EBIT Margin
12.68%8.16%19.18%26.89%31.42%
EBITDA Margin
22.93%18.71%27.23%33.95%37.80%
Operating Profit Margin
9.15%8.16%9.21%15.74%20.90%
Pretax Profit Margin
21.59%19.21%18.55%26.37%30.93%
Net Profit Margin
15.83%14.04%15.19%20.91%24.15%
Continuous Operations Profit Margin
15.75%13.94%15.01%20.86%24.12%
Net Income Per EBT
73.34%73.10%81.90%79.31%78.10%
EBT Per EBIT
235.85%235.41%201.43%167.56%147.94%
Return on Assets (ROA)
5.36%4.35%5.33%7.25%10.59%
Return on Equity (ROE)
12.23%10.59%12.31%16.21%23.12%
Return on Capital Employed (ROCE)
5.11%4.04%4.73%7.89%14.48%
Return on Invested Capital (ROIC)
2.82%2.26%3.22%5.44%9.06%
Return on Tangible Assets
5.48%4.44%5.45%7.46%10.91%
Earnings Yield
9.79%7.76%8.27%8.84%5.29%
Efficiency Ratios
Receivables Turnover
 4.84 4.56 4.98 4.62 5.34
Payables Turnover
 64.91 41.04 34.37 26.42 28.69
Inventory Turnover
 0.99 1.10 1.26 0.98 1.64
Fixed Asset Turnover
 0.93 0.90 0.93 1.00 1.33
Asset Turnover
 0.34 0.31 0.35 0.35 0.44
Working Capital Turnover Ratio
 15.72 8.85 5.92 5.21 8.88
Cash Conversion Cycle
 436.78 401.52 353.42 436.31 277.69
Days of Sales Outstanding
 75.34 80.04 73.33 78.97 68.29
Days of Inventory Outstanding
 367.06 330.37 290.70 371.15 222.12
Days of Payables Outstanding
 5.62 8.89 10.62 13.81 12.72
Operating Cycle
 442.40 410.42 364.04 450.13 290.41
Cash Flow Ratios
Operating Cash Flow Per Share
 0.00 200.01 168.99 50.60 96.18
Free Cash Flow Per Share
 0.00 75.74 -91.72 -156.10 -22.86
CapEx Per Share
 0.00 124.28 260.70 206.70 119.04
Free Cash Flow to Operating Cash Flow
 0.00 0.38 -0.54 -3.08 -0.24
Dividend Paid and CapEx Coverage Ratio
 0.00 1.15 0.54 0.20 0.54
Capital Expenditure Coverage Ratio
 0.00 1.61 0.65 0.24 0.81
Operating Cash Flow Coverage Ratio
 0.00 0.20 0.20 0.08 0.21
Operating Cash Flow to Sales Ratio
 0.00 0.26 0.22 0.08 0.16
Free Cash Flow Yield
0.00%5.36%-6.41%-10.39%-0.83%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 10.23 12.89 12.10 11.31 18.89
Price-to-Sales (P/S) Ratio
 1.62 1.81 1.84 2.37 4.56
Price-to-Book (P/B) Ratio
 1.32 1.37 1.49 1.83 4.37
Price-to-Free Cash Flow (P/FCF) Ratio
 0.00 18.67 -15.60 -9.63 -120.30
Price-to-Operating Cash Flow Ratio
 0.00 7.07 8.47 29.70 28.59
Price-to-Earnings Growth (PEG) Ratio
 1.69 -1.77 -1.10 -1.30 -1.26
Price-to-Fair Value
 1.32 1.37 1.49 1.83 4.37
Enterprise Value Multiple
 10.06 13.41 9.31 8.74 12.94
Enterprise Value
 78.12B 81.59B 82.15B 78.48B 122.71B
EV to EBITDA
 10.05 13.41 9.31 8.74 12.94
EV to Sales
 2.30 2.51 2.53 2.97 4.89
EV to Free Cash Flow
 0.00 25.88 -21.51 -12.08 -128.94
EV to Operating Cash Flow
 0.00 9.80 11.68 37.25 30.65
Tangible Book Value Per Share
 964.09 993.63 912.33 768.69 592.34
Shareholders’ Equity Per Share
 1.00K 1.04K 961.35 819.45 629.62
Tax and Other Ratios
Effective Tax Rate
 0.27 0.27 0.19 0.21 0.22
Revenue Per Share
 814.67 781.25 778.58 635.36 602.70
Net Income Per Share
 129.00 109.69 118.29 132.86 145.57
Tax Burden
 0.73 0.73 0.82 0.79 0.78
Interest Burden
 1.70 2.35 0.97 0.98 0.98
Research & Development to Revenue
 0.07 0.07 0.07 0.07 0.03
SG&A to Revenue
 0.33 0.33 0.35 0.07 0.02
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 0.00 1.82 1.43 0.38 0.52
Currency in JPY